Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT00071487 · COMPLETED

Trial details

NCT number: NCT00071487
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2003-10-01
Primary completion: 2005-08-01
Enrollment: 449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.